Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126354431 | 12635443 | 1 | I | 20160710 | 20160803 | 20160808 | 20160808 | EXP | RO-ABBVIE-16P-135-1694232-00 | ABBVIE | 67.35 | YR | F | Y | 0.00000 | 20160808 | CN | COUNTRY NOT SPECIFIED | RO |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126354431 | 12635443 | 1 | PS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | 2 IN THE MORNING (2-0-0) | Y | UNKNOWN | 206619 | FILM-COATED TABLET | |||||||
126354431 | 12635443 | 2 | SS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Y | UNKNOWN | 206619 | ||||||||||
126354431 | 12635443 | 3 | SS | EXVIERA | DASABUVIR | 1 | Oral | 1 IN THE MORNING AND 1 IN THE EVENING (1-0-0) | Y | UNKNOWN | 206619 | FILM-COATED TABLET | |||||||
126354431 | 12635443 | 4 | SS | EXVIERA | DASABUVIR | 1 | Y | UNKNOWN | 206619 | ||||||||||
126354431 | 12635443 | 5 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | UNKNOWN | 0 | TABLET | ||||||||
126354431 | 12635443 | 6 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | UNKNOWN | 0 | TABLET | BID | |||||||
126354431 | 12635443 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNKNOWN | 0 | |||||||||||
126354431 | 12635443 | 8 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
126354431 | 12635443 | 9 | C | VITAMIN C | ASCORBIC ACID | 1 | UNKNOWN | 0 | |||||||||||
126354431 | 12635443 | 10 | C | BETAMETHASONE. | BETAMETHASONE | 1 | UNKNOWN | 0 | CREAM |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126354431 | 12635443 | 1 | Hepatitis C |
126354431 | 12635443 | 2 | Hepatic cirrhosis |
126354431 | 12635443 | 3 | Hepatic cirrhosis |
126354431 | 12635443 | 4 | Hepatitis C |
126354431 | 12635443 | 5 | Hepatitis C |
126354431 | 12635443 | 6 | Hepatic cirrhosis |
126354431 | 12635443 | 7 | Product used for unknown indication |
126354431 | 12635443 | 8 | Product used for unknown indication |
126354431 | 12635443 | 9 | Product used for unknown indication |
126354431 | 12635443 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126354431 | 12635443 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126354431 | 12635443 | Chest pain | |
126354431 | 12635443 | Decreased appetite | |
126354431 | 12635443 | Dizziness | |
126354431 | 12635443 | Faeces soft | |
126354431 | 12635443 | Fall | |
126354431 | 12635443 | Oedema peripheral | |
126354431 | 12635443 | Rash erythematous | |
126354431 | 12635443 | Speech disorder | |
126354431 | 12635443 | Vomiting | |
126354431 | 12635443 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126354431 | 12635443 | 1 | 20160710 | 20160801 | 0 | |
126354431 | 12635443 | 3 | 20160710 | 20160801 | 0 | |
126354431 | 12635443 | 5 | 20160710 | 20160726 | 0 | |
126354431 | 12635443 | 7 | 20160715 | 20160725 | 0 | |
126354431 | 12635443 | 8 | 20160726 | 20160801 | 0 | |
126354431 | 12635443 | 9 | 20160715 | 20160725 | 0 |